The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma

Multiple myeloma (MM) is a plasma cell malignancy that is often driven by chromosomal translocations. In particular, patients with t(4;14)-positive disease have worse prognosis compared to other MM subtypes. Herein, we demonstrated that t(4;14)-positive cells are highly dependent on the mevalonate (...

Descripción completa

Detalles Bibliográficos
Autores principales: Longo, Joseph, Smirnov, Petr, Li, Zhihua, Branchard, Emily, van Leeuwen, Jenna E., Licht, Jonathan D., Haibe-Kains, Benjamin, Andrews, David W., Keats, Jonathan J., Pugh, Trevor J., Trudel, Suzanne, Penn, Linda Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359767/
https://www.ncbi.nlm.nih.gov/pubmed/32665698
http://dx.doi.org/10.1038/s41375-020-0962-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359767/
https://www.ncbi.nlm.nih.gov/pubmed/32665698
http://dx.doi.org/10.1038/s41375-020-0962-2

Ejemplares similares